Abstract
Objectives
The EORTC Quality of Life (QL) Group has developed a questionnaire, the EORTC QLQ-PR25, for evaluating QL in prostate cancer. The aim of this study is to assess the psychometric properties of the EORTC QLQPR25 when applied to a sample of Spanish patients.
Materials and methods
One hundred and thirty-seven prostate cancer patients with localised disease who started radiotherapy with radical intention combined with or without hormonotherapy prospectively completed the EORTC QLQ-C30 and EORTC QLQ-PR25 questionnaires three times: on the first and last day of radiotherapy and in the follow-up period. Psychometric evaluation of the questionnaires’ structure, reliability and validity was conducted.
Results
Multitrait scaling analysis showed that many of the item-scale correlation coefficients met the standards of convergent and discriminant validity. Exceptions appeared mainly in the scales for bowel symptoms and for hormonal-treatment-related symptoms. Cronbach’s coefficients of the scales were good (0.72–0.86) for the urinary symptoms and sexual function scales but they were lower (<0.70) for the bowel and hormonal treatment scales. Most scales of the EORTC QLQ-PR25 had low to moderate intercorrelations. Correlations between the scales of the QLQ-C30 and the module were generally low. Group comparison analyses showed better QL in patients with higher Performance Status. Changes in QL appeared throughout the measurements. These were in line with the treatment process.
Conclusions
The EORTC QLQ-PR25 was a reliable and valid instrument when applied to a sample of Spanish prostate cancer patients. These results are in line with those of the EORTC validation study.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Oesterling J, Funks Z, Lee CT, Scher HI (2000) Cáncer de próstata. In: De Vita V, Hellman S, Rosenberg SA (eds) Cáncer: principios y práctica de oncología, 5th Edn. Editorial Médica Panamericana, Madrid, pp 1322–1385
Roth A, Scher H (1998) Genitourinary malignancies. In: Holland J (ed.) Psycho-oncology. Oxford University Press, New York, pp 349–358
Lintz K, Moynihan C, Steginga S et al (2003) Prostate cancer patients’ support and psychological care needs: survey from a non-surgical oncology clinic. Psych Oncol 12:769–783
Lee WR, Hall MC, McQuellon RP et al (2001) A prospective quality of life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiation Oncology Biol Phys 51:614–623
Aaronson NK, Ahmezdai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a Quality of Life instrument for use in intentional clinical trials. J Natl Cancer Inst 85:365–376
Aaronson NK, Cull A, Kaasa S, Sprangers M (1994) The EORTC modular approach to Quality of Life assessment in Oncology. Int J Ment Health 23:75–96
Van Andel G, Bottomley A, Fossa S et al (2008) An international field study of the EORTC QLQPR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 44:2418–2424
Esper P, Mo F, Chodak G et al (1998) Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50:920–928
Batista-Miranda JE, Sevilla-Cecilia C, Torrubia R et al (2003) Quality of life in prostate cancer patients and controls: psychometric validation of the FACTP-4 in Spanish, and relation to urinary symptoms. Arch Esp Urol 56:447–454
Litwin MS, Hays RD, Fink A et al (1998) The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36:1002–1012
Wei JT, Dunn RL, Litwin MS et al (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899–905
Giesler RB, Miles BJ, Cowen ME, Kattan MW (2000) Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res 9:645–665
Morales A, Grau G, Campoy P et al (2002) Validation of ESCAP-CDV as an instrument of measure for the evaluation of the quality of life in prostatic cancer. Part 2a. Actas Urol Esp 26:320–334
Carballido J, Tisaire JL, Perulero N (2008) Development of a questionnaire to evaluate the impact of hot flashes in quality of life in patients with advanced prostate cancer. The ESCAPA study. Med Clin 130:561–567
Tabachnik BJ, Fidel LS (1993) Using multivariate statistics. Harper & Row, London
Bjordal K, de Graeff A, Fayers PM et al (2000) A 12 country field study of the EORTC QLQC30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 36:1796–1807
Arraras JI, Arias F, Tejedor M et al (2002) The EORTC QLQ-C30 (version 3.0) quality of life questionnaire. Validation study for Spain with head and neck cancer patients. Psych Oncol 11:249–256
Arraras JI, Villafranca E, Arias F et al (2008) The EORTC Quality of life questionnaire OLO-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Arch Esp Urol 61:949–954
Cull A, Sprangers M, Bjordal K et al (2002) EORTC Quality of Life Group translation procedure, 2nd Edn. EORTC, Brussels
Karnofsky DA, Burchenal JH (1948) The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed.) Evaluation of chemotherapeutic agents. Colombia University, New York, pp 199–205
Ware JE, Harris WJ, Gandek B et al (1997) MAP-R for windows: multitrait multi-item analysis program — revised user’s guide. Health Assessment Lab, Boston
Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297
Arraras JI, Vera R, Martínez M et al (2006) Quality of Life assessment through the EORTC questionnaires of colorectal cancer patients in advanced disease stages. Clin Transl Oncol 8:664–671
Arraras JI, Arias F, Vera R et al (2006) Quality of Life assessment through the EORTC questionnaires of locally advanced rectal cancer patients treated with preoperative chemo-radiotherapy. Clin Transl Oncol 8:423–429
Arraras JI, Illarramendi JJ, Tejedor M et al (2000) Quality of life in Spanish breast cancer patients assessed with the EORTC questionnaires. Rev Oncol 3:100–106
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arraras, J.I., Villafranca, E., Arias de la Vega, F. et al. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients. Clin Transl Oncol 11, 160–164 (2009). https://doi.org/10.1007/S12094-009-0332-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/S12094-009-0332-z